Navigation Links
Data Presented at Cancer Molecular Markers Meeting Suggests Clinical Benefit for Integrating New Molecular Tests
Date:10/31/2008

, genomic diagnostic tests can establish an appropriate place in the practice of evidence-based medicine."

"While it is important to note that tissue identification in the clinical setting utilizes clinical information in addition to IHC results, such as biopsy site, patient gender, age, clinical history and imaging techniques, the results of this analysis clearly demonstrate the opportunity for the Pathwork(R) Tissue of Origin Test to complement IHC in the clinic," said Deborah J. Neff, President and Chief Executive Officer of Pathwork Diagnostics.

About the Study

A literature search was conducted to identify all studies published since 1990 designed to quantify IHC performance in tissue determination. Five studies met the pre-defined criteria; more than 50 appropriately masked specimens and including more than three tissue types. These studies evaluated the successful identification from among three to seven different tissue types using a panel of seven to 10 different IHC tests. Data from the five studies were separated into two subgroups: metastatic tumors only (n=368 specimens), and blended studies that combined primary tumors and metastases (n=298 specimens). The meta-analysis found that IHC tests provided the correct tissue identification for 82.3% of the blended primary and metastatic samples and 65.6% of metastatic cancers, confirming the clinical need for improved diagnostic methods in tissue of origin determination.

About the Pathwork Tissue of Origin Test

The Pathwork Tissue of Origin Test uses a microarray to measure the expression pattern, comprising more than 1,500 genes, in the tumor and compares it to expression patterns of a panel of 15 known tumor types, representing 60 morphologies overall, to help determine the tumor's origin. Earlier this year, the test received FDA clearance, making Pathwork the first company of U.S. origin to receive clearance for a molecular diagnostics test under the U.S. Food and Drug Adm
'/>"/>

SOURCE Pathwork Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
2. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
3. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
4. Results of Colon Cancer Study Utilizing Pressure Cycling Technology (PCT) Presented at the American College of Gastroenterology Annual Scientific Meeting
5. Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics
6. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
7. Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference
8. Salugens Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis
9. Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
10. Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
11. Promising Data ATIR Studies Presented by NIH Investigators

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...es, Dec. 2 Spectrum Blue Steel is ...y companies on the planet. Through the efforts of ...esident and Recycling Specialist Leroy Johnston, w...years, stated that Spectrum Blue Steel is light ye... spectacular earnings because of the bi products r...
(Date:12/2/2009).... 2 The world,s first concept demo..., a breakthrough alternative to replace a petroche...synthetic rubber with renewable biomass, made thei...e will be on display at a lounge in the common dep...t throughout December 21, while the other tire wil...
(Date:12/2/2009)... Mass., Dec. 2 TechConnect World, ...gy development and product integration in cleantec...ber 11th deadline for technology abstracts and bus...echConnect World, in association with the Nano Sci...n Technology and Sustainable Industries Organizati...
(Date:12/2/2009).... 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc....bal biopharmaceutical company focused on endocrine...S. Food and Drug Administration (FDA) has granted ...pathway inhibitor compound, perifosine (KRX-0401),... myeloma. Keryx Biopharmaceuticals, Inc. ("Keryx")...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...% over First Quarter 2007, EMERYVILLE, Calif., Ma...oday reported its financial results,for the first ...come of,$15.4 million, or $0.27 per diluted share,...oss of $12.2 million, or $0.26 per diluted share, ... reported by Bayer HealthCare Pharmaceuticals,Inc....
...s and Ratify Auditor at Annual Meeting, DEERFIELD...ternational Inc. (NYSE: BAX ) today announced a q... Annual Meeting of Shareholders,held earlier today...ly dividend of $0.2175,per share of Baxter common ...he current rate. The quarterly dividend is payable...
...h Corporation,(Nasdaq: SIAL ) will be presenting ...on Tuesday, May 13th at 10:40 AM Pacific Time in L... live audio broadcast over the,Internet available ...he,"Webcast" icon to access this file. For the web...ed to have Media Player software,which can be down...
Other Biology Technology:Onyx Pharmaceuticals Reports 2008 First Quarter Results 2Onyx Pharmaceuticals Reports 2008 First Quarter Results 3Onyx Pharmaceuticals Reports 2008 First Quarter Results 4Onyx Pharmaceuticals Reports 2008 First Quarter Results 5Onyx Pharmaceuticals Reports 2008 First Quarter Results 6Onyx Pharmaceuticals Reports 2008 First Quarter Results 7
(Date:12/2/2009)...PHIA Exposure to secondhand smoke for a prolonged...the risk of breast cancer, even in women who never...of whether exposure to side-stream smoke could inc...ved," said Peggy Reynolds, Ph.D., senior research ...,s Berkeley office. "While no single epidemiologic...
(Date:12/2/2009)...team comprised of undergraduate students from Stev... in a national poster contest hosted by the Intern...PE). , The annual contest highlights the researc...h at the ISPE Annual Meeting in San Diego, Calif. ...sterior Criciate Ligament Tensioning Device," was ...
(Date:12/2/2009)...y on the smokeless tobacco product called moist sn...s in Minnesota to urge the tobacco industry to cha...ent of carcinogens. Their study is published onlin...xicology . It reports that this category of tobacc...rtain toxic and cancer-causing substances. Called ...
Breaking Biology News(10 mins):Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 1Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 2Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 3Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 4Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 5Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 6Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 7Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 8Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 9Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 10Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 11Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 12Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 13Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 14Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 15Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 16Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 17Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 18Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 19Full Transcript of House Democrats Press Conference on Introduction of Health Care Legislation 51726 20Pelosi Remarks at Press Conference on Introduction of Health Care Legislation 51722 1Pelosi Remarks at Press Conference on Introduction of Health Care Legislation 51722 2Pelosi Remarks at Press Conference on Introduction of Health Care Legislation 51722 3MedicAlert Foundation and Autism Society Launch New Program to Safeguard Individuals and Families Living With Autism 51717 1MedicAlert Foundation and Autism Society Launch New Program to Safeguard Individuals and Families Living With Autism 51717 2MedicAlert Foundation and Autism Society Launch New Program to Safeguard Individuals and Families Living With Autism 51717 3
... croaks, chirps and ribbits of dozens of frog spec...that,s decimating amphibian populations worldwide....d for more than a decade, but until recently scien...rs the larger ecosystem. A University of Georgia s...an ecosystem before and after an amphibian populat...
...nt of Psychological Sciences introduced an additio...he Brain Imaging Center (BIC). The BIC will allow ...iseases that can have tremendous impact, including...her neurocognitive disorders using magnetic resona...g Center is a state-of-the-art neuroimaging resear...
...udy The Australian Imaging, Biomarker and Lifesty...s first collaborative research agreement with a ma... AIBL is the world,s largest study of its type, an...r,s disease and to discover a method for early dia... Preventative Health Flagship which involves colla...
Other Biology News:UGA study reveals ecosystem-level consequences of frog extinctions 2UGA study reveals ecosystem-level consequences of frog extinctions 3MU brain imaging center provides research for autism, schizophrenia and Parkinson's disease 2Alzheimer's disease research attracts first partner 2
...ti-purpose, high gel-strength agarose suitable for...m conventional constant field to Pulsed Field Gel ...th and exclusion limits, Multi ABgarose can effect...nning times. This in turn means reduced band diffu...
...is a molecular screening, low melting point agaros...g. It is recommended for separation of nucleic aci...icro ABgarose is also suited to capillary electrop...ques. At a 3% concentration, Micro ABgarose gels a...
Sheep Anti-Salmonella Shoreditch Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Drosophila Melanogaster Achaete protein Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Biology Products: